Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Matthew M. Goodwin"'
Autor:
Garima Dahiya, MD, Daniel Bensimhon, MD, Matthew M. Goodwin, PharmD, John F. Mohr, PharmD, Tamas Alexy, MD, PhD
Publikováno v:
Structural Heart, Vol 6, Iss 4, Pp 100076- (2022)
The steadily rising prevalence of heart failure (HF) and the associated increase in health care expenditures represent a significant burden for patients, caregivers, and society. Ambulatory management of worsening congestion is a complex undertaking
Externí odkaz:
https://doaj.org/article/911357b0749a4fbba2e6351d524b28f4
Autor:
Marya D Zilberberg, Brian H Nathanson, Katherine Sulham, John F Mohr, Matthew M Goodwin, Andrew F Shorr
Publikováno v:
ClinicoEconomics and Outcomes Research.
Marya D Zilberberg,1 Brian H Nathanson,2 Katherine Sulham,3 John F Mohr,3 Matthew M Goodwin,3 Andrew F Shorr4 1EviMed Research Group, LLC, Goshen, MA, USA; 2Optistatim, LLC, Longmeadow, MA, USA; 3scPharmaceuticals, Burlington, MA, USA; 4Washington Ho
Autor:
Daniel Bensimhon, Tamas Alexy, Kathleen L. Deering, Matthew M. Goodwin, Donald Haas, Dalton McLean, Stefanie J. Millar, John F. Mohr, Frank Peacock, William S. Weintraub
Publikováno v:
Heart & Lung. 55:171-172
Autor:
Daniel Bensimhon, Kathleen L. Deering, Matthew M. Goodwin, Donald Haas, John F. Mohr, Dalton McLean, Tamas Alexy, Frank Peacock, William S. Weintraub
Publikováno v:
Heart & Lung. 55:178-179
Autor:
Daniel Bensimhon, William S. Weintraub, W. Frank Peacock, Tamas Alexy, Dalton McLean, Donald Haas, Kathleen L. Deering, Stefanie J. Millar, Matthew M. Goodwin, John F. Mohr
Publikováno v:
SSRN Electronic Journal.
Publikováno v:
Journal of Cardiac Failure. 26:S123
Introduction Heart failure (HF) affects nearly 6.5 million people in the US and it is the leading cause of hospitalizations in adults >65 with costs accounting for 17% of overall national health expenditures. We conducted an analysis to evaluate the
Autor:
Anthony D. Andre, John Mohr, Barbara Cornelius, Matthew M. Goodwin, Carson Whitaker, Bhavini Patel, Michael Hassman
Publikováno v:
Journal of Cardiac Failure. 26:S68
Introduction Furoscix is a novel, pH-neutral formulation of furosemide administered by a 5-hour subcutaneous infusion. The bioavailability compared to IV furosemide is 99.6%, thus Furoscix has the potential for hospital avoidance and reduction of hos
Autor:
Lukas Stulik, Adriana Badarau, Scott A. Van Wart, Eszter Nagy, Matthew M Goodwin, Paul G. Ambrose, Christopher M. Rubino, Harald Rouha, Zehra Visram
Publikováno v:
Open Forum Infectious Diseases
Background ASN100 is a combination of two co-administered fully human monoclonal antibodies (mAbs), ASN-1 and ASN-2, that together neutralize the six cytotoxins critical to S. aureus pneumonia pathogenesis. ASN100 is in development for prevention of
Publikováno v:
The Annals of pharmacotherapy. 45(2)
OBJECTIVE: To evaluate the safety and efficacy of the thienopyridines in order to identify their current place in therapy for the treatment of acute coronary syndrome (ACS). DATA SOURCES: Literature was accessed through MEDLINE (1966-October 2010 wee
Autor:
Peled Y; Leviev Heart & Vascular Center, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel; Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, Israel. Electronic address: Yael.Peled-Potashnik@sheba.health.gov.il., Ducharme A; Deparment of Medicine, Montreal Heart Institute, Université de Montréal, Montreal, Quebec, Canada. Electronic address: anique.ducharme@umontreal.ca., Kittleson M; Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA., Bansal N; Icahn School of Medicine at Mount Sinai, New York, New York, USA., Stehlik J; Division of Cardiovascular Medicine, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA., Amdani S; Department of Pediatric Cardiology, Cleveland Clinic Children's, Cleveland, Ohio, USA., Saeed D; Heart Center Niederrhein, Helios Hospital Krefeld, Krefeld, Germany., Cheng R; Division of Cardiology, University of Washington, Seattle, WA, USA., Clarke B; Division of Cardiology, University of British Columbia, St Paul's Hospital, Vancouver, British Columbia, Canada., Dobbels F; Academic Centre for Nursing and Midwifery, Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium., Farr M; Division of Cardiology, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX; Parkland Health System, Dallas, TX, USA., Lindenfeld J; Division of Cardiovascular Medicine, Vanderbilt University, Nashville, TN, USA., Nikolaidis L; Baylor Scott & White Medical Center, Temple, TX, USA., Patel J; Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA., Acharya D; Division of Cardiovascular Diseases, University of Arizona Sarver Heart Center, Tucson, Arizona, USA., Albert D; Department of Paediatric Cardiology, Paediatric Heart Failure and Cardiac Transplant, Heart Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia., Aslam S; Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, La Jolla, California, USA., Bertolotti A; Heart and Lung Transplant Service, Favaloro Foundation University Hospital, Buenos Aires, Argentina., Chan M; University of Alberta Hospital, Edmonton, Alberta, Canada., Chih S; Heart Failure and Transplantation, Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada., Colvin M; Department of Cardiology, University of Michigan, Ann Arbor, MI; Scientific Registry of Transplant Recipients, Hennepin Healthcare Research Institute, Minneapolis, MN, USA., Crespo-Leiro M; Cardiology Department Complexo Hospitalario Universitario A Coruna (CHUAC), CIBERCV, INIBIC, UDC, La Coruna, Spain., D'Alessandro D; Massachusetts General Hospital, Boston; Harvard School of Medicine, Boston, MA, USA., Daly K; Boston Children's Hospital & Harvard Medical School, Boston, MA, USA., Diez-Lopez C; Advanced Heart Failure and Heart Transplant Unit, Department of Cardiology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain., Dipchand A; Division of Cardiology, Department of Paediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada., Ensminger S; Heart Center Lübeck, University Hospital, Lübeck, Germany., Everitt M; Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO, USA., Fardman A; Leviev Heart & Vascular Center, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel; Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, Israel., Farrero M; Department of Cardiology, Hospital Clínic, Barcelona, Spain., Feldman D; Newark Beth Israel Hospital & Rutgers University, Newark, NJ, USA., Gjelaj C; Department of Cardiovascular and Thoracic Surgery, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA., Goodwin M; Division of Cardiothoracic Surgery, University of Utah, Salt Lake City, UT, USA., Harrison K; Department of Pharmaceutical Services, Vanderbilt University Medical Center, Nashville, TN, USA., Hsich E; Cleveland Clinic Foundation, Division of Cardiovascular Medicine, Cleveland, OH, USA., Joyce E; Department of Cardiology, Mater University Hospital, Dublin, Ireland; School of Medicine, University College Dublin, Dublin, Ireland., Kato T; Department of Cardiology, International University of Health and Welfare School of Medicine, Narita, Chiba, Japan., Kim D; University of Alberta & Mazankowski Alberta Heart Institute, Edmonton, Alberta, Canada., Luong ML; Division of Infectious Disease, Department of Medicine, University of Montreal Hospital Center, Montreal, Quebec, Canada., Lyster H; Department of Heart and Lung Transplantation, The Royal Brompton and Harefield NHS Foundation Trust, Harefield Hospital, Harefield, Middlesex, UK., Masetti M; Heart Failure and Transplant Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Matos LN; Hospital Pró-Cardíaco, Rio de Janeiro, Brazil., Nilsson J; Department of Cardiothoracic and Vascular Surgery, Skane University Hospital, Lund, Sweden., Noly PE; Department of Surgery, Montreal Heart Institute, Montreal, Quebec, Canada., Rao V; Division of Cardiac Surgery, University of Toronto, Toronto, Ontario, Canada., Rolid K; Department of Cardiology, Oslo University Hospital, Rikshospitalet, Oslo, Norway., Schlendorf K; Division of Cardiology, Vanderbilt University Medical Center, Nashville, TN, USA., Schweiger M; University Children's Hospital, Zurich, Switzerland., Spinner J; Section of Pediatric Cardiology, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA., Townsend M; Division of Pediatric Cardiology, Stollery Children's Hospital, Edmonton, Alberta, Canada., Tremblay-Gravel M; Deparment of Medicine, Montreal Heart Institute, Université?de Montréal, Montreal, Quebec, Canada., Urschel S; Stollery Children's Hospital, University of Alberta, Edmonton, Alberta, Canada., Vachiery JL; Department of Cardiology, Cliniques Universitaires de Bruxelles, Hôpital Académique Erasme, Bruxelles, Belgium., Velleca A; Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA., Waldman G; Department of Pharmacy, Massachusetts General Hospital, Boston, MA, USA., Walsh J; Allied Health Research Collaborative, The Prince Charles Hospital, Brisbane; Heart Lung Institute, The Prince Charles Hospital, Brisbane, Australia.
Publikováno v:
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation [J Heart Lung Transplant] 2024 Oct; Vol. 43 (10), pp. 1529-1628.e54. Date of Electronic Publication: 2024 Aug 08.